[
  {
    "id": "f03458f6ca0ded28",
    "title": "UBS downgrades GE HealthCare to “sell” on valuation, competitive risks",
    "link": "https://www.investing.com/news/stock-market-news/ubs-downgrades-ge-healthcare-to-sell-on-valuation-competitive-risks-4449014",
    "summary": "",
    "body": null,
    "image": null,
    "pubDate": "2026-01-15T10:40:26.000Z",
    "source": {
      "name": "Investing.com News (EN)",
      "homepage": "https://www.investing.com/rss/news.rss"
    },
    "lang": "en",
    "category": "health",
    "region": "global"
  },
  {
    "id": "b01dc6e9c5a4029a",
    "title": "Healthy Returns: Novo Nordisk CEO on GLP-1 pricing, and more insights from the JPM conference",
    "link": "https://www.cnbc.com/2026/01/14/healthy-returns-novo-nordisk-ceo-glp-1-pill-jpmorgan-conference.html",
    "summary": "Novo Nordisk's CEO spoke about GLP-1 pricing and Pfizer's CEO spoke about the company's obesity ambitions while at the JPMorgan Healthcare Conference.",
    "body": null,
    "image": null,
    "pubDate": "2026-01-14T18:14:05.000Z",
    "source": {
      "name": "CNBC — Markets",
      "homepage": "https://www.cnbc.com/id/100003114/device/rss/rss.html"
    },
    "lang": "en",
    "category": "health",
    "region": "global"
  }
]